1 Erratum to: Pharmacoeconomics (2012) 30 (12):1157–1171 DOI 10.2165/11598470-000000000-00000

Page 1164, Table III, final column: please see the following table for two minor corrections to the bolded values in the final column under the QALYs discounted section.

Table III Results from the base-case analysis of Sativex® plus oral medicines against oral medicines for spasticity due to MS over 5 years